University of Minnesota/Masonic Cancer Center — Minneapolis, Minnesota

Public research footprint of University of Minnesota/Masonic Cancer Center, compiled from the ClinicalTrials.gov public registry.

322

Registered studies

127

Active

Recruiting now

153

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Ovarian Carcinoma · Botryoid-Type Embryonal Rhabdomyosarcoma · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Recurrent Skin Squamous Cell Carcinoma With Sarcomatoid…

Recently updated registry entries

NCT05099003 — A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed… (Recruiting)
NCT04089358 — Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young… (Active Not Recruiting)
NCT04616560 — Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Minnesota/Masonic Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.